Dimensional Fund Advisors LP Neuronetics, Inc. Transaction History

Dimensional Fund Advisors LP

$376 Billion
Q2 2024

A detailed history of Dimensional Fund Advisors LP transactions in Neuronetics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 128,069 shares of STIM stock, worth $96,051. This represents 0.0% of its overall portfolio holdings.

Number of Shares

128,069

Previous 147,005 12.88%

Holding current value

$96,051

Previous $699,000 67.1%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$1.73 - $4.81 $32,759 - $91,082	-18,936 Reduced 12.88%	128,069 $230,000
Q1 2024 May 10, 2024	BUY	$2.68 - $4.8 $86,706 - $155,294	32,353 Added 28.22%	147,005 $699,000
Q4 2023 Feb 07, 2024	BUY	$1.05 - $2.9 $42,250 - $116,693	40,239 Added 54.08%	114,652 $332,000
Q3 2023 Nov 09, 2023	SELL	$1.29 - $2.22 $271,723 - $467,616	-210,638 Reduced 73.89%	74,413 $100,000
Q2 2023 Aug 09, 2023	SELL	$2.07 - $2.92 $184,219 - $259,865	-88,995 Reduced 23.79%	285,051 $612,000
Q1 2023 May 12, 2023	BUY	$2.81 - $6.71 $516,404 - $1.23 Million	183,774 Added 96.58%	374,046 $1.09 Million
Q4 2022 Feb 09, 2023	BUY	$2.74 - $6.87 $245,205 - $614,803	89,491 Added 88.8%	190,272 $1.31 Million
Q3 2022 Nov 10, 2022	BUY	$2.35 - $4.66 $168,647 - $334,424	71,765 Added 247.33%	100,781 $319,000
Q2 2022 Aug 12, 2022	SELL	$2.09 - $3.71 $3,074 - $5,457	-1,471 Reduced 4.83%	29,016 $94,000
Q4 2021 Feb 09, 2022	BUY	$3.87 - $6.59 $64,563 - $109,940	16,683 Added 120.86%	30,487 $135,000
Q3 2021 Nov 12, 2021	SELL	$6.22 - $15.54 $7,022 - $17,544	-1,129 Reduced 7.56%	13,804 $90,000
Q2 2021 Aug 12, 2021	SELL	$10.15 - $17.25 $24,451 - $41,555	-2,409 Reduced 13.89%	14,933 $239,000
Q4 2020 Feb 25, 2021	BUY	$4.95 - $11.45 $85,842 - $198,565	17,342 New	17,342 $193,000

Others Institutions Holding STIM

# of Institutions

Shares Held

18.3M

Call Options Held

Put Options Held

3.8K

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $20.3M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Neuronetics, Inc. Transaction History